Little change was observed for S Tob as antibiotic release cannot be determined using EDX.
Introduction
Biomaterial associated infections are of major concern in surgery. Microorganisms are frequently introduced onto implant surfaces and subsequently into the body [1] . It has been reported that infection rates range from 0.8-1.2% in orthopaedic surgery (total hip arthroplasty) and 3.6-8.1% (closed fracture) to 17.5%- 21 .2% (open fractures) in trauma surgery [2] . Sepsis can ultimately lead to failure of the arthroplasty, causing the need for revision surgery, prolonged hospitalization and even death [3] . The field of biomedical engineering relies heavily on the interaction between the biomaterials and the surrounding physiological environment [4] and recently additives have been included in biomaterial design to increase antibacterial properties in an effort to extend the longevity of the implant. Some examples include antibiotic coatings, antibiotic-loaded collagen sheets and cement spacers [5] and antibiotic-loaded bone cements (ALBC). Commercially, ALBCs consist of a PMMA based cement with additions of antibiotics such as tobramycin, gentamicin [6, 7] , vancomycin and erythromycin [7] . However concerns related to the use of ALBCs include the long term effectiveness of the released drug [6, 7] and promotion of bacterial resistance which is likely due to the long-term sub-therapeutic levels of antibiotic eluted from the cement [6] . Other additives such as chitosan and collagen have been added to materials in order to promote cell growth [7] . Chlorhexidine (CHX) has also been added to dental glass polyalkenoate cements (GPCs) to further improve antibacterial properties [8] .
However CHX was found to interfere in the setting reaction of commercially tested GPCs resulting in reduced mechanical properties [8] .
GPCs, traditionally used in dental applications, generally contain ions that impart an antibacterial nature when used in an oral aqueous environment. The antimicrobial nature of these cements is predominantly due to the release of the fluoride ion (F -) [9] [10] [11] and also related to setting occuring at a low pH [12] . GPCs have the additional ability to uptake and re-release F -ions in a F -rich aqueous environment, which can impart a prolonged antibacterial response [10] .
However, translating GPCs from dental to orthopaedic applications highlights concerns relating to the composition of the material, in particular the presence of aluminium (Al) in the glass phase which can cause neurological [13, 14] and bone metabolic defects [15] . The GPCs produced in this work have zinc ions (Zn 2+ ) substituting for Al ions (Al 3+ ) as numerous studies report on the antibacterial efficiency [12, [16] [17] [18] and positive bone metabolic effects of Zn [19, 20] .
For this study a range of commercially available materials were selected for testing. [21] , due to the presence of adherent, multilayered biofilms on the surfaces of implanted biomedical devices which are less susceptible to antibiotics compared to their planktonic counterparts [22] . P. aeruginosa has been found to infect surgical procedures such as Total Knee Arthroplasty (TKA) [23] , and is reported to be the cause of osteomyelitis in pelvic bones [24] . It has also, along with E. coli, been found to constitute 42% of polymicrobial infections in the spine [21] . This infection rate is preceded by S. aureus and S. epidermidis which are the primary cause of infection in the majority of postoperative spinal infections [21] . These species are prevalent in human epithelia residing on most skin and mucous membranes and are known to cause nosocomial infections in newborns, severely ill and immuno-compromised patients [25] . Further studies on biopsies of the spine by Heyer et al reveal the presence of all of these bacteria, highlighting the relevance of this study [26] .
For this work, a novel GPC formulation alongside Simplex + Tobramycin, Spineplex and Novabone Putty, were tested against E. coli, S. epidermidis, P. aeruginosa and S. aureus.
Materials
 Simplex P + Tobramycin (S Tob. ) -Stryker Howmedica, Limerick, Ireland (#0473S024).
 BT 101 + 10wt% TSC (B TSC ) -Experimental GPC.
 Spineplex (S pine ) -Stryker Howmedica, Limerick, Ireland (#V1104).
 Novabone Putty (N Put. )-Gian Medical, Birmingham, UK (#0610D5).
Glass Synthesis
A strontium-calcium-zinc-silicate glass formulation (0.04SrO/0.12CaO/0.36 ZnO/0.48 SiO 2 , mol. fraction) was synthesized. The glass was prepared by weighing out appropriate amounts of analytical grade reagents (Sigma-Aldrich, Dublin, Ireland) and ball milling for one hour. The mixture was then dried in an oven (100ºC, 1 hour), fired (1480ºC, 1 hour) in a platinum crucible and shock quenched in water. The resulting frit was dried, ground and sieved to retrieve a glass powder with a maximum particle size of 45 m.
Polyacrylic Acid (PAA)
The Polyacrylic Acid (PAA) used in this study (E9, M w 80,800) was supplied by Advanced Healthcare Limited (Kent, UK). The polyacrylic acid was ground and sieved to retrieve <90μm particles.
Tri-Sodium Citrate (TSC)
The TSC used in this study was obtained from Reagacon (Shannon, Ireland) and was incorporated into the cement at 10 wt% addition.
Tobramycin Sulfate (Tob)
The Tob used in this study was obtained from Stryker Howmedica (Limerick, Ireland) and was incorporated into the cement at 2.5 wt% addition; a concentration similar to that contained in S Tob .
Cement Preparation
Cements were prepared by thoroughly mixing the glass powder with the PAA and distilled water (BT 101) on a glass plate using a dental spatula at a powder to liquid ratio of 2:1.5 g/mL. Additions of 10 wt% TSC / 2.5wt% Tob were also added to the cement formulations as outlined in table 1. Table 1 Formulation of cements used in this study.
Sample Preparation
Three specimens of S Tob , BT TSC , S pine and N Put were used for testing in each bacterium. Each sample was produced by filling moulds (2 mm x 8 mmØ) with the cement and leaving them to set for 1 hr prior to testing. Samples were produced under standard sterile laboratory conditions.
A short maturation study was undertaken to determine the antibacterial properties of the experimental GPC containing Tobramycin (B Tob ) against S Tob . For this study both materials were immersed in similar concentrations of sterile water for 1, 7 and 14 days. The cement were then 
Agar Disc-Diffusion Test
The antibacterial activity of the cements was evaluated against E. coli strain DH5α, B, S.
epidermidis strain NCIMB 12721, P. aeruginosa strain PA01 and S. aureus strain A35-4 using the agar disc-diffusion method. Luria agar and broth were used for the culture of E. coli, BHI agar and broth were used for culturing S. epidermidis, P. aeruginosa and S. aureus. All organisms were grown at 37ºC. Preparation of the agar disc-diffusion plates involved seeding the agar plates with a sterile swab dipped in a 1/50 dilution of the appropriate 16 h culture of bacteria. Three discs of each material were placed on the inoculated plates and the plates were cultured for 24 hours at 37ºC. The agar diffusion test was performed under standard laboratory sterile conditions using a fumigation hood with sterile swabs for inoculation of bacteria.
Electronic calipers were used to measure zones of inhibition at three different diameters for each disc and zone sizes were calculated as follows:
All cements were analysed in triplicate and mean zone sizes ± standard deviations were calculated.
Preparation of Agar Specimens
Agar strips (3 x 10 x 5mm) were prepared for investigation by EDX from the agar diffusion test. The specimens were cut from the assay, extending from the cement disc, through any inhibition zone, through to the bacterial colony. The agar specimens were then placed on a glass slide and incubated at 37 o C in an air assisted oven for 24 hours until dry.
Results and Discussion
The primary objective of this study was to investigate the antibacterial response of a number of commercially available materials and one experimental material in an in vitro model. of cultures where intermittent catheterization was required in joint arthroplasty [27] . In relation to this study the biomaterials tested had more success in eliminating E. coli than any of the other bacteria examined. Figure 1 shows sample images of the agar diffusion test performed with S.
epidermidis Figure 2 a.) shows the commercial materials and experimental GPC tested against E.
coli. coli. Statistical analysis was performed between each material for variance, and this was done for each bacterium. It was found that there are significant differences between the two cements that showed inhibition, S Tob and B TSC (p=0.001). S Tob and B TSC showed significant differences when compared with all other materials tested, (figure 2 a.) also there was found to be no significant difference between S pine and N Put (p=1.000), as these materials showed no inhibition. This was similar for all bacterium tested where S pine and N Put showed no inhibition for S. epidermidis, P.
aeruginosa and S. aureus (p=1.000) as shown in figure 2 b. ), c.) & d. With respect to each bacteria, S Tob was found to be bacteriocidal and outperformed each of the competing materials. This is due to the presence of the antibiotic Tobramycin (Tob). Tob is is generally used to treat gram-ve bacterial infections such as skin or bone, lower respiratory tract and central nervous system (CNS) infections [28] . Studies by Le Goffic et al describes Tob mechanism of action in relation to E. coli. Tob was found to occupy two binding sites on the ribosomes of the bacterial cell. The primary one is likely responsible for the inhibition of protein synthesis whereas the secondary one is related to the misreading of the messenger RNA [29] . Tob has also previously been used to treat P. aeruginosa infections in patients with cystic fibrosis [30, 31] , and has been described by D'Arrigo et al to show excellent in vitro and clinical activities against susceptible strains of E. coli and S. aureus by inhibiting plasma membrane functions and by targeting ribosomal sites [32] . However, overuse of antibiotics in medicine promoted the evolution of some species of bacteria to infer resistance. These include the Methicillin resistant S.aureus (MRSA) and S. epidermidis (MRSE) strains which are responsible for a considerable amount of hospital acquired infections [33] [34] [35] . The primary reason for increased usage of antibiotics in implant related infections is that bacteria change their biological behavior when adhering to implant surfaces [2] . They produce a biofilm which forms a protective barrier and they can also reduce their metabolic activity and increase their generation time. As antibiotics act on growing bacteria, an increased minimum inhibitory concentration (MIC) of antibiotic is required to affect bacteria with reduced metabolic activity. Studies have found that 800 fold higher MIC for Tob in adhesive P. aeruginosa than for non-adhesive [2, 7] . Concerns also arise regarding the quantity of antibiotic released and the longevity around the implant site. After the high initial release of antibiotics, the long-term low concentration around implants may also contribute to antibiotic resistant strains [2, 7] . The effectiveness of such materials is dependent on the rate and manner of which the drug is released, and this is directly related to the host material [7] . Drug release from materials is achieved through mechanisms of water pore penetration, soluble matrix dissolution and diffusion of the solubilized drug via matrix imperfections (pores/cracks). However PMMA based materials display a biphasic release pattern characterized by a high initial release followed by a long tail of low, ineffective and largely incomplete release that continues for days or months. Studies reveal that less than 10% of the trapped drug is eventually released from the cement [7] . Another concern is that antibiotics such as Tob can have harmful side effects in the body. Tob belongs to a group called aminoglycosides which are known to be nephrotoxic and ototoxic, depending on the choice of aminoglycoside and duration of therapy [36] . Increasing the dosage of antibiotic to reach the MIC when combating adherent biofilms may subsequently result in more trauma to local tissues.
To determine the efficacy of antibiotic release from S Tob and a GPC (B Tob ), testing was performed on S. epidermidis over a period of 0-14 days. Figure 3 shows the comparison of S Tob and B Tob in S. epidermidis with respect to maturation. From figure 3 it can be seen that there is a significant decrease in antibacterial efficacy from 0 days (17.4±0.4mm) through to 14 days (9.8±0.01mm) regarding S Tob . However there is no significant change when comparing 1, 7 and 14 days (p=0.589, 1.000, 1.000 table 3a). This suggests that the set material is retaining some of the antibiotic in the bulk and that the surface antibiotic has solubilized and was expended after initial testing at 0 days. B Tob on the other hand was found to show a significant (p=0.041) increase in inhibition over the period of 0 days (5.7±0.4mm) to 14 days (7.4±0.3mm). It was expected that B Tob would perform better than the results obtained here as GPCs are ion leachable materials. However this may be the reason for the lower results found as compared to S Tob . It may be possible that ion processes within the cement are reducing the efficacy of the antibiotic. Considering this, however, antibacterial efficacy was found to increase with respect to maturation. Table 3b confirms that there remains a significant change in inhibition between S Tob and B Tob at initial testing, 0 days and after 14 days. It is evident from figure 4a that there is little change in the composition of the agar regarding S Tob . This is due to EDX not being able to identify complex chemical structures. Figure 4b reveals the presence of approximately 1wt% Zn whereas no Zn was found in the control agar. There was also a small quantity of Sr (0.1wt%) detected, where again, no Sr was present in the control agar. It is difficult to determine the precise mechanism by which B TSC is exhibiting antimicrobial properties as TSC present in the cement is known to be an antibacterial agent itself [37, 38] . Previous work by the authors determined that TSC prolongs the setting [39] of this cement facilitating greater ion release [40] . It has also been previously been reported that by increasing the concentration of TSC and Zn ion release, the antibacterial efficacy of the material increases [40] . Zn is an antibacterial ion which acts as an inhibitor of multiple activities in the bacterial cell, such as glycolysis, transmembrane proton translocation and acid tolerance [41] . It has also been cited by Shashibhushan et al that Zn can interfere with substrate transport and oxidation and can react with thiol groups on the bacterial cell wall [18] . Zn can also change protein structure leading to inhibition of specific metabolic enzymes, thereby causing growth inhibition [18] . Another possible reason for inhibition by B TSC could be explained by the mechanism of action of TSC, which is known to chelate Ca [42] , which in this case slows the setting reaction in these cements [39] . However, regarding bacterial inhibition, TSC may be binding any Ca being used by the bacteria for metabolism. There was no antibacterial effect attributed to S pine and N Put , however there were slight changes in the EDX patterns. Figure 4c shows that there was an increase in the phosphorus (P) concentrations as compared to the control agar. This may be due to bacteria metabolising as they proliferate on the surface of the agar.
There was also a very slight increase in P content in the agar surrounding N Put (figure 4d). These materials exhibited no antibacterial properties when tested against these bacteria as S pine , in particular, contains no antimicrobial compounds or ions. This cement is implanted and remains as an inert material exhibiting no bioactivity. N Put is based on a Bioglass formulation suspended in a gelatin binder, however the composition failed to inhibit the proliferation of the bacteria tested.
To conclude, S Tob was the only material to exhibit antibacterial properties when tested in each bacterium. However the ongoing discussion as regards the overuse of antibiotics suggests that additional ways of combating infection would be welcome. B TSC was the only other material to exhibit antibacterial properties and this was only evident against E. coli and S. epidermidis.
The advantage of using a GPC over an acrylic cement is that beneficial ions can be absorbed and re-released when in an ion rich environment. However further research is required to evaluate at what extent this occurs. S pine and N Put are two commercially available materials that were found to exhibit no antibacterial properties, and as such this leaves room for development of more bioactive materials with properties suitable for use in orthopaedics.
